gamma-carboline has been researched along with scopolamine hydrobromide in 1 studies
| Studies (gamma-carboline) | Trials (gamma-carboline) | Recent Studies (post-2010) (gamma-carboline) | Studies (scopolamine hydrobromide) | Trials (scopolamine hydrobromide) | Recent Studies (post-2010) (scopolamine hydrobromide) |
|---|---|---|---|---|---|
| 44 | 0 | 26 | 7,548 | 563 | 1,401 |
| Protein | Taxonomy | gamma-carboline (IC50) | scopolamine hydrobromide (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.003 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 0.006 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.0006 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0026 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appenroth, D; Enzensperger, C; Fleck, C; Gaube, F; Lehmann, J; Otto, R; Penzis, R; Tränkle, C; Winckler, T | 1 |
1 other study(ies) available for gamma-carboline and scopolamine hydrobromide
| Article | Year |
|---|---|
Beta and gamma carboline derivatives as potential anti-Alzheimer agents: A comparison.
Topics: Adjuvants, Anesthesia; Alzheimer Disease; Animals; Anti-Anxiety Agents; Carbolines; Cognition Disorders; Female; Maze Learning; Memory Disorders; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Scopolamine; Structure-Activity Relationship | 2014 |